Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
Atavistik Bio, Inc
Compass Therapeutics
Alterome Therapeutics, Inc.
Eli Lilly and Company
BeOne Medicines
Context Therapeutics Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
BioNTech SE
IDEAYA Biosciences
MacroGenics
Doma Biopharmaceutical(Suzhou)Co., Ltd.
M.D. Anderson Cancer Center
GlaxoSmithKline
Sairopa B.V.
NeoTX Therapeutics Ltd.
West China Hospital
Incyte Corporation
Tempest Therapeutics
Pfizer
Exelixis
Numab Therapeutics AG
Totus Medicines
NextPoint Therapeutics, Inc.
Pfizer
Theratechnologies
Seagen Inc.
Agenus Inc.
Checkpoint Therapeutics, Inc.
Astellas Pharma Inc
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Danatlas Pharmaceuticals Co., Ltd
Brown University
Xencor, Inc.
Pliant Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
Celon Pharma SA
Corvus Pharmaceuticals, Inc.
QuantumLeap Healthcare Collaborative
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Incyte Corporation
MacroGenics
Eisai Inc.
Abramson Cancer Center at Penn Medicine
Merrimack Pharmaceuticals
Santa Maria Biotherapeutics